Kestra Advisory Services’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,825
Closed -$150K 2156
2022
Q1
$150K Sell
13,825
-2,850
-17% -$34.6K ﹤0.01% 1898
2021
Q4
$235K Sell
16,675
-175
-1% -$2.88K ﹤0.01% 1778
2021
Q3
$324K Buy
16,850
+5,350
+47% +$71K ﹤0.01% 1622
2021
Q2
$113K Hold
11,500
﹤0.01% 1941
2021
Q1
$113K Sell
11,500
-6,857
-37% -$56.5K ﹤0.01% 1800
2020
Q4
$90K Buy
18,357
+7,157
+64% +$32.4K ﹤0.01% 1790
2020
Q3
$48K Buy
+11,200
New +$79.9K ﹤0.01% 1386

Other funds holding DVAX

Kestra Advisory Services's DVAX Position: Q2 2022 in Review

Kestra Advisory Services sold out of Dynavax Technologies (DVAX) in Q2 2022, closing a stake of 13,825 shares — an estimated $150K sold.

Kestra Advisory Services first reported a position in DVAX in Q3 2020 and held it in 7 quarters. The position peaked at $324K in Q3 2021. 209 funds tracked by Wall St. Rank hold DVAX as of Q2 2022.

  • Kestra Advisory Services reported no remaining Dynavax Technologies position as of Q2 2022 after selling out during the quarter.
  • Kestra Advisory Services sold 13,825 Dynavax Technologies shares in Q2 2022, an estimated $150K.
  • Kestra Advisory Services first reported a position in Dynavax Technologies in Q3 2020 and held it in 7 quarters.
  • Kestra Advisory Services's Dynavax Technologies position peaked at $324K in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2022.

Based on Kestra Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.